According to the announcement from Weixinkang (603676.SH), the company's cooperative production partner, Shanxi Pude Pharmaceutical Co., Ltd. (referred to as "Pude Pharmaceutical"), has recently received the approval notice for the supplementary application of injectable multivitamins (12) issued by the National Medical Products Administration. This drug has passed the consistency evaluation of quality and efficacy for generic drugs. Injectable multivitamins (12) are independently developed by the company, with Pude Pharmaceutical responsible for drug registration and production, making it a core product of the company.

Injectable multivitamins (12) are used for intravenous vitamin supplementation and are suitable for adults and children over 11 years old who cannot or have insufficient oral nutrition (malnutrition, poor absorption, parenteral nutrition, etc.) and need to supplement vitamins through injection